OROLBO'YI SHAROITIDA SAKUBILTRIL VA EMPAGLIFLAZIN KOMBINATSIYASI SURANKALI YURAK YETISHMOVCHILIGIDA XAYOT SIFATI VA GEMODINAMIKA KO'RSATKICHLARIGA TA'SIRI

20260 citationsJournal Articlegreen Open Access

Authors

Inomjon Islomov · Technological Educational Institute of Eastern Macedonia and Thrace

Baxrom Fayzullayev · University of Kaiserslautern

Umida Normatova · Korea Advertising Society

Abstract

Mazkur maqolada 2-toifa qandli diabet fonida surunkali yurak yetishmovchiligi hamda uning o‘tkir dekompensatsiyasi bilan og‘rigan, chiqarish fraksiyasi pasaygan bemorlarni davolash masalasi tahlil qilinadi. Chiqarish fraksiyasi past bo‘lgan yurak yetishmovchiligi (ChFPYY) bugungi kunda eng muhim tibbiy va ijtimoiy muammolardan biri bo‘lib qolmoqda, ayniqsa u 2-toifa diabet bilan birgalikda kechganda. 2016 yilda sakubitril/valsartan kombinatsiyasi Yuperio savdo nomi ostida ro‘yxatdan o‘tkazildi va ushbu toifadagi bemorlarda kasalxonaga yotqizilish hamda o‘lim xavfini sezilarli darajada kamaytirishi isbotlandi. Keyinchalik farmatsevtika amaliyotida ushbu kombinatsiyaning qo‘llanilishi klinik amaliyotda kengayib bordi.

Topics & Keywords

Education, Innovation and Language Studies Economic and Industrial Development Medical, Sociocultural, and Biopolitical Studies

Publication Details

Published in: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.18864952

Field-Weighted Citation Impact: 0.00

Command Palette

OROLBO'YI SHAROITIDA SAKUBILTRIL VA EMPAGLIFLAZIN KOMBINATSIYASI SURANKALI YURAK YETISHMOVCHILIGIDA XAYOT SIFATI VA GEMODINAMIKA KO'RSATKICHLARIGA TA'SIRI

Authors

Abstract

Topics & Keywords

Publication Details